Physician profile
Matthew James Deorio
NPI 1366422727
$48,776.01
in general payments reported to CMS, 2019-2025
34 companies · $41K in 2025
The $41K reported for 2025 was more than what 89% of Foot and Ankle Surgery providers received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,902 · 2020: $316 · 2021: $1,266 · 2022: $790 · 2023: $2,371 · 2024: $956 · 2025: $41K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $40K · Food and Beverage: $3,826 · Travel and Lodging: $940.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $39,735.88 |
| Food and Beverage | $3,826.02 |
| Travel and Lodging | $939.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exactech, INC. | $42,766.08 | 2019-2025 | |
| Stryker Corporation | $1,756.60 | 2019-2025 | Inbone, Infinity Adaptis, Augment Injectable |
| Paragon 28, INC. | $920.55 | 2019-2025 | Smart28, Avitus Bone Graft Harvester |
| Smith+Nephew, INC. | $452.39 | 2019-2025 | Renasys Go V2 Home, Footprint, Q-Fix |
| Bioventus LLC | $248.61 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Prime Surgical, LLC | $247.23 | 2019-2021 | |
| Wright Medical Technology, INC. | $230.28 | 2019 | |
| Linvatec Corporation | $196.85 | 2024-2025 | Biobrace 23mm, Quantum |
| Abbott Laboratories | $194.13 | 2021-2023 | Proclaim |
| Abbvie INC. | $183.46 | 2022-2025 | Dalvance |
| Kci USA, INC. | $179.66 | 2021-2023 | Prevena, Activ.A.C., Promogran Prisma |
| Novastep INC. | $167.74 | 2021 | |
| Horizon Therapeutics Plc | $161.59 | 2019-2021 | |
| Restor3d, INC. | $148.44 | 2024 | |
| Aroa Biosurgery Incorporated | $140.12 | 2025 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $124.99 | 2024 | Exparel |
| Polynovo North America LLC | $117.84 | 2023-2025 | Novosorb Btm |
| Carbofix Orthopedics INC | $95.81 | 2021 | |
| Kerecis Limited | $87.24 | 2022-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Bone Support INC. | $52.14 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $44.42 | 2022-2023 | Seglentis, Livalo |
| Depuy Synthes Sales INC. | $28.70 | 2019 | |
| Medela LLC | $26.28 | 2023 | Invia Motion Endure |
| Solventum Corporation | $25.60 | 2025 | Prevena, Activ.A.C., V.A.C. Veraflo |
| Biocomposites INC | $21.63 | 2025 | Stimulan |
| Organogenesis INC. | $21.31 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $20.37 | 2025 | |
| Averitas Pharma INC. | $19.43 | 2023 | Qutenza |
| Misonix INC | $18.15 | 2019 | |
| Heron Therapeutics, INC. | $17.58 | 2022 | |
| Allergan, INC. | $16.20 | 2019 | |
| Boston Scientific Corporation | $15.03 | 2023 | Spectra Wavewriter |
| Integra Lifesciences Corporation | $14.81 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Sanara Medtech INC. | $14.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Deorio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.